Reliable time data has become essential for teams that move between offices, homes, and shared digital workspaces. To meet ...

Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") , a leading provider-centric, technology-powered healthcare company enabling providers to ...

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the PreciseOnco consortium, ...

February 3, 2026 Co-funded by the EU's Innovative Health Initiative (IHI), the Philips-coordinated research consortium will ...

The Hims & Hers Multi-Cancer Test by Galleri® looks for a shared signal of 50+ types of cancer, including those without ...

Slimline, phone mountable AI recorder that transcribes, translates and enables the creation of searchable documents that can ...

Significant company transformation through the purchase of real estate and continued progress in the medical device business "We have taken significant steps forward in 2025. For the fourth quarter ...

Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the ...

UK start-up Complement Therapeutics has raised an impressive €72 million ($79 million) in first-round financing that will be used to take a gene therapy for sight-robbing disease geographic atrophy ...

Tear fluid is emerging as an attractive source of diagnostic information because it can be collected easily and ...

There are two types of complement 3 glomerulopathy: dense deposit disease (DDD) and C3 glomerulonephritis (C3GN). DDD often begins earlier in life and may progress more quickly. Both are linked to an ...